Knowledge Center
Patent / Aug 04, 2022
Inhaled ivermectin
Source:
US 20220241307
The present invention contemplates the use of inhaled ivermectin for use in various viruses and parasitic infections (treatment and/or prophylaxis) that are present or manifest in the lungs or respiratory tract. Exemplary dosing, formulations, devices, and processing techniques are also disclosed herein.
Also in the Knowledge Center
Scientific Article
/ Oct 15, 2017
In vitro - in vivo Correlations of Carbamazepine Nanodispersions for Application in Formulation Development
Read more
Scientific Article
/ Nov 12, 2017
Use of Supercritical-CO2 Assisted Spray Drying for the production of Pharmaceutical compounds
Read more
Scientific Article